Kazemifar Samaneh, Barragán Montero Ana M, Souris Kevin, Rivas Sara T, Timmerman Robert, Park Yang K, Jiang Steve, Geets Xavier, Sterpin Edmond, Owrangi Amir
Medical Artificial Intelligence and Automation (MAIA) Laboratory, Department of Radiation Oncology, University of Texas Southwestern Medical Center, Dallas, TX, USA.
Institut de Recherche Expérimentale et Clinique, Center of Molecular Imaging, Radiotherapy and Oncology (MIRO), Université catholique de Louvain, Brussels, Belgium.
J Appl Clin Med Phys. 2020 May;21(5):76-86. doi: 10.1002/acm2.12856. Epub 2020 Mar 26.
The purpose of this study was to address the dosimetric accuracy of synthetic computed tomography (sCT) images of patients with brain tumor generated using a modified generative adversarial network (GAN) method, for their use in magnetic resonance imaging (MRI)-only treatment planning for proton therapy.
Dose volume histogram (DVH) analysis was performed on CT and sCT images of patients with brain tumor for plans generated for intensity-modulated proton therapy (IMPT). All plans were robustly optimized using a commercially available treatment planning system (RayStation, from RaySearch Laboratories) and standard robust parameters reported in the literature. The IMPT plan was then used to compute the dose on CT and sCT images for dosimetric comparison, using RayStation analytical (pencil beam) dose algorithm. We used a second, independent Monte Carlo dose calculation engine to recompute the dose on both CT and sCT images to ensure a proper analysis of the dosimetric accuracy of the sCT images.
The results extracted from RayStation showed excellent agreement for most DVH metrics computed on the CT and sCT for the nominal case, with a mean absolute difference below 0.5% (0.3 Gy) of the prescription dose for the clinical target volume (CTV) and below 2% (1.2 Gy) for the organs at risk (OARs) considered. This demonstrates a high dosimetric accuracy for the generated sCT images, especially in the target volume. The metrics obtained from the Monte Carlo doses mostly agreed with the values extracted from RayStation for the nominal and worst-case scenarios (mean difference below 3%).
This work demonstrated the feasibility of using sCT generated with a GAN-based deep learning method for MRI-only treatment planning of patients with brain tumor in intensity-modulated proton therapy.
本研究旨在探讨使用改进的生成对抗网络(GAN)方法生成的脑肿瘤患者合成计算机断层扫描(sCT)图像的剂量学准确性,以用于质子治疗的仅磁共振成像(MRI)治疗计划。
对脑肿瘤患者的CT和sCT图像进行剂量体积直方图(DVH)分析,以制定调强质子治疗(IMPT)计划。所有计划均使用商用治疗计划系统(RaySearch Laboratories公司的RayStation)和文献中报道的标准稳健参数进行稳健优化。然后使用IMPT计划在CT和sCT图像上计算剂量以进行剂量学比较,使用RayStation分析(笔形束)剂量算法。我们使用第二个独立的蒙特卡罗剂量计算引擎在CT和sCT图像上重新计算剂量,以确保对sCT图像的剂量学准确性进行适当分析。
从RayStation提取的结果表明,对于标称情况下在CT和sCT上计算的大多数DVH指标,一致性极佳,临床靶区(CTV)的平均绝对差异低于处方剂量的0.5%(0.3 Gy),所考虑的危及器官(OARs)低于2%(1.2 Gy)。这表明生成的sCT图像具有高剂量学准确性,尤其是在靶区内。从蒙特卡罗剂量获得的指标在标称和最坏情况场景下大多与从RayStation提取的值一致(平均差异低于3%)。
本研究证明了使用基于GAN的深度学习方法生成的sCT用于脑肿瘤患者调强质子治疗的仅MRI治疗计划的可行性。